Precisome™ Clinical Avatar Technology is a platform developed by NemaMetrix Inc., a biotechnology company founded in 2011 in Eugene, Oregon. The mission of the Precisome™ Technology is to reduce the cost and improve efficiency of treating patients with rare genetic disorders.
NemaMetrix develops solutions and proprietary systems for the genetic modification of simple microscopic living animals to act as human proxies for disease research and drug discovery, and to help researchers and scientists reveal new insights into the true nature of genetic mutations.
Vice President of R&D
Richard brings over 15 years of experience in identifying, assessing, developing and integrating cutting-edge technologies into high revenue products, including nucleic acid and protein sample preparation, reverse transcription, real-time PCR, NGS, and single cell analysis.
Chief Scientific Officer
Chris pioneered the commercialization of C. elegans transgenics. As a scientist turned entrepreneur, he now pioneers the application of humanized animal models for clinical phenomics.
Vic President of Marketing & Sales
Wenlan brings a wide range of experience in brand and product marketing, integrated marketing communications, marketing operations, and financial analysis from the biotech and IT industries.
Vice President of Operations
Brian brings more than 20 years of experience in Operations Management and operational performance including Lean Manufacturing, Six-Sigma and Quality Engineering in the Biotech industry. He has led teams ranging from product packaging to fine chemical manufacturing to antibody and immunology consumables production.
Board of Directors
Chief Operating Officer, Digital Trends
Chris Carlson is an entrepreneur and investor with experience in finance and digital media. After starting his career as a proprietary trader for UBS O’Connor and Deutsche Bank, he founded his own fund Caesium Capital, which invested in traditional and alternative assets managing over $100mln. Following the successful exit of Caesium Capital, Chris was co-founder and COO of MusicQubed, a micro-payment based digital music service which provides private label services for Telefonica, Vodafone and MTV among others. Following the sale of a majority stake to Viacom, Chris returned with his family to Oregon and has been actively involved in the entrepreneurial community.
Chris has made investments in a number of Oregon based startups and currently sits on the Boards of NemaMetrix and Gathrly.
Vice President of Corporate Strategy, BD Biosciences
Evangeline Gonzalez has more than 17 years of commercialization experience within the biotechnology industry and has successfully led Market Development and Product Development for a wide array of global businesses ranging from Protein Analysis, Sequencing and Molecular Biology technologies.
Gonzalez joins Advanced Cell Diagnostics from Life Technologies, a 3.7 billion dollar company where she was most recently Chief Marketing Officer- Life Sciences and was responsible for facilitating growth and global market development strategy for the Life Science Division.
As the inventor of the NemaMetrix core system (the ScreenChip), Shawn brings his expertise in C.elegans, neurophysiology, and microfluidics for biological applications.
Co-Founder, Rogue Venture Partners
Rick Miller is a seventh generation Oregonian who enjoys starting and growing businesses and helping other entrepreneurs do the same. In 2010 Miller co-founded the private equity firm, Rogue Venture Partners, to invest in Oregon based entrepreneurs and early stage businesses with funding and mentorship. After successfully deploying its first and second funds, Rogue is now investing its third fund, Rogue Venture Partners Fund III.
Senior Principal & Co-Founder, Obsidian
Kevin D. Padrick has a strong finance and banking background as a Senior Principal and co-founder of Obsidian Finance. Due in part to his success as an entrepreneur in both regulated and non-regulated industries, and in part to his work as an advisor, Mr. Padrick has broad experience in business transactions involving natural resources.
We are scientists, researchers, barrier breakers. We strive for the awesome.